US 12,435,077 B2
Oxazolidinone compound and methods of use thereof as an antibacterial agent
Brendan M. Crowley, Collegeville, PA (US); Philippe Nantermet, Lansdale, PA (US); David B. Olsen, Lansdale, PA (US); Takao Suzuki, Shanghai (CN); Lihu Yang, Edison, NJ (US); and Lanying You, Shanghai (CN)
Assigned to Merck Sharp & Dohme LLC, Rahway, NJ (US)
Appl. No. 17/909,834
Filed by Merck Sharp & Dohme LLC, Rahway, NJ (US)
PCT Filed Mar. 20, 2021, PCT No. PCT/US2021/022652
§ 371(c)(1), (2) Date Sep. 7, 2022,
PCT Pub. No. WO2021/188606, PCT Pub. Date Sep. 23, 2021.
Claims priority of application No. PCT/CN2020/080359 (WO), filed on Mar. 20, 2020.
Prior Publication US 2024/0208958 A1, Jun. 27, 2024
Int. Cl. C07D 417/10 (2006.01); A61K 31/541 (2006.01); A61K 45/06 (2006.01); A61P 31/06 (2006.01)
CPC C07D 417/10 (2013.01) [A61K 31/541 (2013.01); A61K 45/06 (2013.01); A61P 31/06 (2018.01)] 24 Claims
 
1. A compound of Formula I

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.